| 000 | 01854 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516115003.0 | ||
| 264 | 0 | _c20121217 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1097-6744 | ||
| 024 | 7 |
_a10.1016/j.ahj.2012.06.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDillinger, Jean-Guillaume | |
| 245 | 0 | 0 |
_aBiological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cOct 2012 |
||
| 300 |
_a600-606.e1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aArachidonic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Resistance _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
| 700 | 1 | _aDrissa, Akram | |
| 700 | 1 | _aSideris, Georgios | |
| 700 | 1 | _aBal dit Sollier, Claire | |
| 700 | 1 | _aVoicu, Sebastian | |
| 700 | 1 | _aManzo Silberman, Stephane | |
| 700 | 1 | _aLogeart, Damien | |
| 700 | 1 | _aDrouet, Ludovic | |
| 700 | 1 | _aHenry, Patrick | |
| 773 | 0 |
_tAmerican heart journal _gvol. 164 _gno. 4 _gp. 600-606.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ahj.2012.06.008 _zAvailable from publisher's website |
| 999 |
_c22186177 _d22186177 |
||